3 Reasons This Is the Best Dividend Stock to Buy in May

Hormel’s dividend yield is 5.6% and the company has raised its payout for 59 straight years, reinforcing its Dividend King status. Analysts are bullish on the turnaround, with a median price target of $27 implying 31% upside, while fiscal 2026 operating income guidance of $1.06 billion to $1.12 billion supports the recovery case. The stock is down 13% year to date and trades at a forward P/E of 14 and price-to-sales ratio of 0.95.

Analysis

HRL is increasingly a duration trade disguised as a defensive staple: the market is paying up for current cash yield while underappreciating how much of the rerating depends on execution in the next 2-4 quarters. The key second-order effect is that cost-out plus portfolio pruning can create a sharper-than-expected margin inflection if input inflation stays contained, because packaged food names often re-rate faster on evidence of operating leverage than on absolute revenue growth.

The setup is asymmetric versus the broader consumer staples complex. If management hits its operating-income bridge, the stock can move from being treated like a bond proxy to a self-help compounder, which typically compresses the implied risk premium by 1-2 turns of forward multiple even before earnings revisions catch up. That matters because a stable high yield can attract income buyers, but the real upside comes from the market’s willingness to pay a higher multiple for credible, repeatable margin repair.

The main risk is that the turnaround becomes a slower grind rather than a clean inflection: pricing pressure from private label, weak protein economics, or execution slippage in supply-chain rationalization would delay the thesis and keep the stock trapped in yield-seeking ownership. In that scenario, the dividend likely remains intact, but the equity can still underperform if investors decide the payout is compensating for stagnant growth rather than signaling a durable cash-flow rerating.

Contrarian angle: consensus may be too focused on yield and too optimistic on the path to multiple expansion. For a business like this, the market usually rewards proof, not plans, so the best entry may be after a first or second quarter where margin improvement is visible in realized numbers rather than guidance; absent that, the stock can remain a value trap for another 1-2 reporting cycles.

Key Decisions for Investors

• Long HRL on a 3-6 month horizon as a self-help + income trade, but size it as a catalyst-driven position rather than a core staple holding; risk/reward improves if the stock stays below the low-$30s and management prints sequential margin improvement.
• Pair long HRL / short a basket of slower-turning packaged-food peers with weaker balance sheets and less visible cost-out, to isolate execution alpha from sector beta; target a 6-9 month hold until the market differentiates margin repair from pure yield.
• If already long income equities, consider replacing part of a low-yield consumer staples position with HRL only after confirming operating-income traction, since the rerating from proof of execution can be 1-2 turns of P/E over 2-3 quarters.
• For tactical traders, sell put spreads or use cash-secured puts one earnings cycle out to get paid while waiting for evidence; the trade works best if implied vol remains elevated versus the stock’s realized movement.
• Avoid chasing into strength if the market is already pricing the turnaround; upside is still real, but the cleaner entry is on any post-earnings reset where the dividend yield re-expands and the turnaround thesis is not yet fully validated.